Table 1.
Pre (N = 13) | Post (N = 17) | |
---|---|---|
Female, n (%) | 5 (39) | 11 (65) |
Age, median (range) | 78 (71–89) | 76 (71–96) |
eGFR, mL/min per 1.73 m2, mean (range) | 16 (12–18) | 16 (10–24) |
Comorbidities | % afflicted | % afflicted |
Coronary artery disease | 54 | 24 |
Diabetes | 39 | 59 |
Heart failure | 39 | 24 |
Cancer | 39 | 30 |
Peripheral vascular disease | 15 | 12 |
Pulmonary hypertension | 8 | 6 |
COPD | 8 | 0 |
Cerebrovascular disease | 0 | 6 |
Has at least two comorbidities | 92 | 94 |
Has at least three comorbidities | 62 | 59 |
COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate.